156 related articles for article (PubMed ID: 3707714)
1. Occurrence of lysoganglioside lyso-GM2 (II3-Neu5Ac-gangliotriaosylsphingosine) in GM2 gangliosidosis brain.
Neuenhofer S; Conzelmann E; Schwarzmann G; Egge H; Sandhoff K
Biol Chem Hoppe Seyler; 1986 Mar; 367(3):241-4. PubMed ID: 3707714
[TBL] [Abstract][Full Text] [Related]
2. Composition of gangliosides and neutral glycosphingolipids of brain in classical Tay-Sachs and Sandhoff disease: more lyso-GM2 in Sandhoff disease?
Rosengren B; Månsson JE; Svennerholm L
J Neurochem; 1987 Sep; 49(3):834-40. PubMed ID: 3612128
[TBL] [Abstract][Full Text] [Related]
3. Enzyme-linked immunosorbent assay for the ganglioside GM2-activator protein. Screening of normal human tissues and body fluids, of tissues of GM2 gangliosidosis, and for its subcellular localization.
Banerjee A; Burg J; Conzelmann E; Carroll M; Sandhoff K
Hoppe Seylers Z Physiol Chem; 1984 Mar; 365(3):347-56. PubMed ID: 6724528
[TBL] [Abstract][Full Text] [Related]
4. Lyso-GM2 ganglioside: a possible biomarker of Tay-Sachs disease and Sandhoff disease.
Kodama T; Togawa T; Tsukimura T; Kawashima I; Matsuoka K; Kitakaze K; Tsuji D; Itoh K; Ishida Y; Suzuki M; Suzuki T; Sakuraba H
PLoS One; 2011; 6(12):e29074. PubMed ID: 22205997
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of lysosphingolipids in tissues from patients with GM1 and GM2 gangliosidoses.
Kobayashi T; Goto I; Okada S; Orii T; Ohno K; Nakano T
J Neurochem; 1992 Oct; 59(4):1452-8. PubMed ID: 1402895
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical demonstration of GM2-ganglioside in the central nervous system of a 19-week-old fetus of Tay-Sachs disease.
Taniike M; Inui K; Hirabayashi Y; Tsukamoto H; Nishimoto J; Midorikawa M; Okada S; Yabuuchi H
J Inherit Metab Dis; 1989; 12 Suppl 2():372-4. PubMed ID: 2512447
[No Abstract] [Full Text] [Related]
7. Characterization of some minor gangliosides in Tay-Sachs brains.
Yu RK; Itoh T; Yohe HC; Macala LJ
Brain Res; 1983 Sep; 275(1):47-52. PubMed ID: 6414648
[No Abstract] [Full Text] [Related]
8. Accumulation of ganglioside Gm2 in cerebrospinal fluid of a patient with the variant AB of infantile Gm2 gangliosidosis.
Pullarkat RK; Reha H; Beratis NG
Pediatrics; 1981 Jul; 68(1):106-8. PubMed ID: 7243492
[TBL] [Abstract][Full Text] [Related]
9. Presence of an unusual GM2 derivative, taurine-conjugated GM2, in Tay-Sachs brain.
Li YT; Maskos K; Chou CW; Cole RB; Li SC
J Biol Chem; 2003 Sep; 278(37):35286-91. PubMed ID: 12829702
[TBL] [Abstract][Full Text] [Related]
10. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
Charrow J; Binns HJ
Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
[TBL] [Abstract][Full Text] [Related]
11. [Identification of GM2-gangliosidosis using an in vitro loading test].
Akhunov VS; Krasnopol'skaia KD
Vopr Med Khim; 1987; 33(4):115-9. PubMed ID: 3116767
[TBL] [Abstract][Full Text] [Related]
12. GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease.
Demir SA; Timur ZK; Ateş N; Martínez LA; Seyrantepe V
J Neuroinflammation; 2020 Sep; 17(1):277. PubMed ID: 32951593
[TBL] [Abstract][Full Text] [Related]
13. Imaging MALDI mass spectrometry using an oscillating capillary nebulizer matrix coating system and its application to analysis of lipids in brain from a mouse model of Tay-Sachs/Sandhoff disease.
Chen Y; Allegood J; Liu Y; Wang E; Cachón-Gonzalez B; Cox TM; Merrill AH; Sullards MC
Anal Chem; 2008 Apr; 80(8):2780-8. PubMed ID: 18314967
[TBL] [Abstract][Full Text] [Related]
14. Prenatal diagnosis of GM2-gangliosidosis. Immunofluorescence analysis of ganglioside GM2 in cultured amniocytes by confocal laser scanning microscopy.
Sakuraba H; Itoh K; Kotani M; Tai T; Yamada H; Kurosawa K; Kuroki Y; Suzuki H; Utsunomiya T; Inoue H
Brain Dev; 1993; 15(4):278-82. PubMed ID: 8250149
[TBL] [Abstract][Full Text] [Related]
15. GM2-ganglioside metabolism in cultured human skin fibroblasts: unambiguous diagnosis of GM2-gangliosidosis.
Raghavan S; Krusell A; Lyerla TA; Bremer EG; Kolodny EH
Biochim Biophys Acta; 1985 Apr; 834(2):238-48. PubMed ID: 3995063
[TBL] [Abstract][Full Text] [Related]
16. Neurophysiological investigations in GM1 and GM2 gangliosidoses.
Pampiglione G; Harden A
Neuropediatrics; 1984 Sep; 15 Suppl():74-84. PubMed ID: 6100798
[TBL] [Abstract][Full Text] [Related]
17. High-resolution loading tests in the study of genetic heterogeneity in gangliosidosis fibroblasts.
Akhunov VS; Mirenburg TV; Krasnopolskaya XD
J Inherit Metab Dis; 1994; 17(1):104-11. PubMed ID: 8051915
[TBL] [Abstract][Full Text] [Related]
18. Preparation of various lysogangliosides including lyso-fucosyl GM1 and delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometric analysis.
Taketomi T; Hara A; Uemura K; Kurahashi H; Sugiyama E
J Biochem; 1997 Feb; 121(2):264-9. PubMed ID: 9089399
[TBL] [Abstract][Full Text] [Related]
19. Brain ceramide hexosides in Tay-Sachs disease and generalized gangliosidosis (GM1-gangliosidosis).
Suzuki K; Chen GC
J Lipid Res; 1967 Mar; 8(2):105-13. PubMed ID: 14564716
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous quantification of GM1 and GM2 gangliosides by isotope dilution tandem mass spectrometry.
Gu J; Tifft CJ; Soldin SJ
Clin Biochem; 2008 Apr; 41(6):413-7. PubMed ID: 18241673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
